Home
Conditions
Uterine Cervical Neoplasms

Clinical trial condition

Uterine Cervical Neoplasms

Explore clinical trials studying Uterine Cervical Neoplasms. Study availability and eligibility vary by location and protocol.

1,588 public trials 355 recruiting studies

Refine in advanced search Browse all conditions

Uterine Cervical Neoplasms trial results

Active, Not Recruiting

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

NCT06197802

Conditions: Cervical Cancer, Communicable Diseases, Condylomata Acuminata, +28 more
Locations: Jiangsu Provincial Centre for Disease Control and Prevention Nanjing, Jiangsu, China

View Trial Details

Active, Not Recruiting

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

NCT06243666

Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia, Disease Attributes, +19 more
Locations: Sheyang County Center for Disease Control and Prevention Yancheng, Jiangsu, China

View Trial Details

Active, Not Recruiting

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

NCT05056402

Conditions: Cervical Cancer, Communicable Diseases, Condylomata Acuminata, +28 more
Locations: Sichuan Provincial Centre for Disease Control and Prevention Chengdu, Sichuan, China

View Trial Details

Active, Not Recruiting

Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial

NCT05996783

Conditions: Cervical Intraepithelial Neoplasia, Cervix Cancer, Female Urogenital Diseases, +16 more
Locations: Universiteit Antwerpen Edegem, Antwerp, Belgium

View Trial Details

Active, Not Recruiting

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

NCT05994300

Conditions: Adaptive Radiotherapy, Cervical Neoplasm, Female Urogenital Diseases, +15 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations: Highlands Oncology Group Springdale, Arkansas, United States

University of California at Davis Davis, California, United States

The Oncology Institute of Hope and Innovation Downey, California, United States

City of Hope Cancer Center Duarte, California, United States

View all 37 locations

View Trial Details

Active, Not Recruiting

Tempus Priority Study: A Pan-tumor Observational Study

NCT05179824

Conditions: Adnexal Diseases, Bile Duct Diseases, Bile Duct Neoplasms, +113 more
Locations: UT Southwestern Dallas, Texas, United States

Baylor College of Medicine Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

NCT04802876

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +111 more
Locations: Grupo SOLTI Barcelona, Spain

View Trial Details

Active, Not Recruiting

Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living with HIV

NCT06402383

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Pamoja Tunaweza Women's Centre Moshi, Tanzania

View Trial Details

Active, Not Recruiting

Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer

NCT04516616

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Tongji Hospital Wuhan, Hubei, China

View Trial Details

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms trial results

Related conditions